Navigation Links
Eva Longoria Parker Participates in 5k Run/Walk to Raise Money for Children With Cancer and Offers Support to Univision Talent Fernando Del Rincon's Cancer Diagnosis
Date:6/2/2008

- Eva Longoria Parker participated in the Inaugural Stand for HOPE! Run/Walk while lending support to her colleague Fernando Del Rincon who

announced his recent cancer diagnosis.

LOS ANGELES, June 2 /PRNewswire/ -- PADRES Contra El Cancer, an organization dedicated to improving the quality of life for children with cancer and their families, hosted its inaugural 5k Run/Walk at the Los Angeles Memorial Coliseum. National Spokespersons Eva Longoria Parker, star of Desperate Housewives, and Fernando Del Rincon, news anchor for Univision's Primer Impacto, joined close to 800 runners and walkers in raising more than fifty thousand dollars that will be used to expand services to families who have a child with cancer in the greater Los Angeles area.

"I am so happy that today was such a wonderful success. This was our inaugural run/walk and it was rewarding to be amongst almost 800 people who found a common cause in PADRES Contra El Cancer and their support of children with cancer and their families," remarked PADRES National Spokesperson Eva Longoria Parker.

Eva Longoria Parker also showed her support for her colleague Fernando Del Rincon, also a spokesperson for PADRES Contra El Cancer, who shared for the first time his recent cancer diagnosis and his personal experience. "I was shocked to hear about Fernando's diagnosis. It is great that his cancer was caught in its early stages. That's why it is so important for everyone, including your children, to have regular health exams," stated Eva Longoria Parker.

Only 3 weeks after his surgery to remove a cancerous tumor in his bladder, Fernando Del Rincon joined the hundreds of runners in running the Inaugural Stand for HOPE! 5k. "I know first-hand the fears every family experiences with a cancer diagnosis. I know what each child feels and fears. I also understand ever more so, why PADRES is such an important organization for so many people. I thank PADRES for supporting
'/>"/>

SOURCE PADRES Contra El Cancer
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. National Spokeswoman Eva Longoria Parker to Accept $200,000 Donation From AT&T to Benefit PADRES Contra El Cancer
2. MedCath Names Parker to New Finance Post
3. HTG-Ventrex, Signalifes Contract Manufacturer, Acquired by Parker Hannifin Corporation
4. Former Dallas Cowboy Honored as Parker College of Chiropractic Top 2008 Graduate
5. Parker Extends Precise Medical Seal Capability; Acquires Hi-Tech Group Companies
6. Parker Waichman Alonso LLP Files Suit Against General Electric Company on Behalf of a Man Who Developed Nephrogenic Systemic Fibrosis (NSF) from Contrast Agent Omniscan
7. Parker Waichman Alonso LLP, Becnel Law Firm, LLC, Douglas & London P.C., Levin
8. Parker Waichman Alonso LLP, Along with Smith & Nevares, Salas & Co. and Becnel
9. The PA Breast Cancer Coalition Participates in 2008 Patient Advocacy Leaders Summit (PALS): PALs (Patient Advocacy Leaders) for a Healthier America!
10. USAID Participates in White House Office of Faith-Based and Community Initiatives Conferences in Rwanda and Zambia
11. ABR-Affinity BioReagents Participates in the 2008 Fisher Scientific Supplier Expo in San Antonio, Texas

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)... EDINA,Minn.,Nov.25/PRNewswire-USNewswire/--Whenmo...Butachiropractorcanalsogivepatientsthehelptheyneed...ereyourjaw(mandible)contacts/connectswithyourskull...tedwithTMJdysfunctionarepainwithchewing,clickingor...mTMJdysfunctionincluding:headaches,fatigue,sleepdi...
(Date:11/25/2009)... TORONTO,Nov.25/PRNewswire/-SentinelleMedicalInc.,...ualizationsoftwarelaunchesasuiteofnewleadingedgecl...wareplatformatthisyear,sRadiologicalSocietyofNorth...009(Booth5800,HallA).Theapplicationsleveragetheuni...izedMRIimagingcoilsandsupportmultipleimagingmodali...
(Date:11/25/2009)... SANFRANCISCO,Nov.25/PRNewswire/--TheBayAreaAirQua...nter Spare the Air Alert forThursday...irelogsoranyothersolidfuel,bothindoorsandoutdoors....airqualitytomorrow,"saidJackBroadbent,executiveoff...orespectthehealthoftheirneighborsandfellowcommunit...
(Date:11/25/2009)...ortuitous discovery that grew out of a collaborati...entially offer hope to the nearly 10 million Ameri... , Also known as hardening of the arteries, p...rculatory problem in which narrowed arteries reduc...ered a red flag for vascular disease, heart attack...
(Date:11/25/2009)... Evaluation and treatment clinic... Woodstock (Vocus) November 25, 2009 -- Centeg... vaccines and H1N1 vaccine shots at four Centegra ...er shipment of vaccine has arrived. The clinics ar... and McHenry and will be open as follows: , &n...
Breaking Medicine News(10 mins):Health News:Sentinelle Medical Launches Aegis Suite of Oncology 4D Visualization Software with PureWeb(TM) Technology 2Health News:Sentinelle Medical Launches Aegis Suite of Oncology 4D Visualization Software with PureWeb(TM) Technology 3Health News:Winter Spare the Air Alert in Effect for Thursday, November 26, 2009 2Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 2Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 3Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 4Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 2Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 3Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 4
...ing to Researchers in CA, FL, IN, ME, NC, NY, SC, ... Physical Activity and Enhance Preventi...ON, N.J., May 27 More than $2 million,in grants w... players, health behaviors and outcomes. The grant...
...g European scientists say that there is an urgent ...tween Europes biobanks repositories of genetic an...hat can be used to investigate complex diseases su...well as increased and sustained funding for bioban...
...study by Newcastle University proves that organic ...d are producing better quality milk. , The Naffer...ing cows on organic farms in the UK produce milk w...ummer months, one of the beneficial fats in partic...
...on enables further growth and product development,...ta,analytics and business intelligence software to...today announced it was acquired by The Advisory,Bo...hance its existing platform and develop new produc...
...ter system enables hospital staff to overcome pote... transfusion safety., LENEXA, Kan., May 27 Mediw...www.mediware.com, a provider of,ClosedLoop(TM) cl...abel scanning and printing with Mediware,s HCLL bl...
... Calif., May 27 Isis,Pharmaceuticals, Inc. (Nasda....6 million dollars from Alnylam Pharmaceuticals, I... fees in the recently announced transaction,betwee...This transaction further emphasizes the value of I...
Other Medicine News:Health News:Video/Online Games for Health: 12 Research Teams From Across U.S. To Receive Major Grants 2Health News:Video/Online Games for Health: 12 Research Teams From Across U.S. To Receive Major Grants 3Health News:Europe's biobanks need urgent coordination -- scientists say 2Health News:UK's organic cows are cream of the crop 2Health News:UK's organic cows are cream of the crop 3Health News:Crimson Announces Acquisition by The Advisory Board Company 2Health News:All Children's Hospital Achieves ISBT 128 Compliance With Mediware's HCLL Blood Bank System 2Health News:All Children's Hospital Achieves ISBT 128 Compliance With Mediware's HCLL Blood Bank System 3Health News:Isis to Receive $4.6 Million From Alnylam 2Health News:Isis to Receive $4.6 Million From Alnylam 3
(Date:11/25/2009)...VELAND,Colo.,Nov.25/PRNewswire-FirstCall/--HeskaCo...nceddiagnosticandspecialtyproductstotheveterinaryi...csCorporationforthesupplyofbloodgasproductsandaffi...go: http://www.newscom.com/cgi-bin/prnh/20000622/H...forinnovatinginthefieldofadvancedpoint-of-carediag...
(Date:11/25/2009)...ICAGOandSTAFA,Switzerland,Nov.25/PRNewswire/-- Fro...vativehearingsolutions,presentedthesecondeditionof...cialneedsoftheolderpopulation.Theconferencebrought...dtheworldandmorethan250clinicianswhoworkeverydaywi...eexperiencesanddiscussthelatestresearchandtrendsin...
(Date:11/25/2009)...LLEGEPARK,Md.,Nov.25/PRNewswire-USNewswire/--Remed...m-likefoamthatstopsseverebleeding,wonfirstprizeand...GlobalSecurityChallenge2009,companyofficialsannoun...roundtheworld,Remedium,steampitchedtheirinventiona...olofBusiness. ,, Remedium( www.remediumtechnolo...
Breaking Medicine Technology:Heska Announces Supply Agreement With Roche Diagnostics 2Heska Announces Supply Agreement With Roche Diagnostics 3Phonak Successfully Hosts Hearing Care for Adults 2009 Conference 2Phonak Successfully Hosts Hearing Care for Adults 2009 Conference 3Remedium Technologies Wins Most Promising Security Idea at Global Security Challenge 2009 with Blood-Clotting Foam 2Remedium Technologies Wins Most Promising Security Idea at Global Security Challenge 2009 with Blood-Clotting Foam 3Preventing H1N1 spread to health care workers 3A Dilemma debate and confusion 61746 1Preventing H1N1 spread to health care workers 3A Dilemma debate and confusion 61746 2USC study to evaluate robots as exercise trainers 61744 1Weill Cornell science briefs 3A November 2009 10815 1Weill Cornell science briefs 3A November 2009 10815 2Weill Cornell science briefs 3A November 2009 10815 3Weill Cornell science briefs 3A November 2009 10815 4Weill Cornell science briefs 3A November 2009 10815 5
...Newswire/ -- Phase 3 results,from the RE-NOVATE(TM...e once daily, administered for an average of 33 da...red for an average of 33,days, in preventing venou...ter total hip replacement surgery. In this trial, ...ran etexilate was,similar to enoxaparin. The incid...
.../ -- A new study suggests,strong variation in the ... southern U.S. Anaphylaxis is a severe allergic,re...inephrine. The,striking north-south differences in... currently are without explanation. The,investigat...in D,from lack of sunshine, may play a role and th...
Other Medicine Technology:Phase 3 Results for Dabigatran Etexilate, an Investigational Oral,Anticoagulant, Presented Today at the XXIst Congress of the,International Society on Thrombosis and Haemostasis 2Phase 3 Results for Dabigatran Etexilate, an Investigational Oral,Anticoagulant, Presented Today at the XXIst Congress of the,International Society on Thrombosis and Haemostasis 3Phase 3 Results for Dabigatran Etexilate, an Investigational Oral,Anticoagulant, Presented Today at the XXIst Congress of the,International Society on Thrombosis and Haemostasis 4Phase 3 Results for Dabigatran Etexilate, an Investigational Oral,Anticoagulant, Presented Today at the XXIst Congress of the,International Society on Thrombosis and Haemostasis 5Large Geographic Differences in EpiPen Prescriptions in the U.S.,From the Journal of Allergy and Clinical Immunology 2
OCUFLOX® 5 mL
ALPHAGAN® 5 mL
ACULAR® 5 mL
ACULAR® 10 mL
Medicine Products: